Page last updated: 2024-11-08

actinorhodin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

actinorhodin: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

actinorhodin : A member of the class of benzoisochromanequinone that is produced by Streptomyces coelicolor A3(2) and exhibits antibiotic activity. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID441143
CHEBI ID2448
SCHEMBL ID95607
SCHEMBL ID1177648
MeSH IDM0061128

Synonyms (19)

Synonym
2,2'-[(1r,1'r,3s,3's)-5,5',10,10'-tetrahydroxy-1,1'-dimethyl-6,6',9,9'-tetraoxo[3,3',4,4',6,6',9,9'-octahydro-1h,1'h-8,8'-binaphtho[2,3-c]pyran]-3,3'-diyl]diacetic acid
CHEBI:2448
actinorhodin
actinorhodine
C06691
1397-77-9
(8,8'-bi-1h-naphtho(2,3-c)pyran)-3,3'-diacetic acid, 3,3',4,4',5,5',10,10'-octahydro-6,6',9,9'-tetrahydroxy-1,1'-dimethyl-5,5',10,10'-tetraoxo-, (1r,1'r,3s,3's)-
2,2'-[(1r,1'r,3s,3's)-6,6',9,9'-tetrahydroxy-1,1'-dimethyl-5,5',10,10'-tetraoxo-3,3',4,4',5,5',10,10'-octahydro-1h,1'h-8,8'-bibenzo[g]isochromene-3,3'-diyl]diacetic acid
g4hh387t6z ,
unii-g4hh387t6z
actinorhodine [mi]
15428-92-9
SCHEMBL95607
SCHEMBL1177648
[3'-carboxymethyl-5,5',10,10'-tetrahydroxy-1,1'-dimethyl-6,6',9,9'-tetraoxo-3,3',4,4'6,6'9,9'-octahydro-1h,1'h-8,8'-bi(benzo[g]isochromen)-3-yl]acetic acid
Q4676996
DTXSID20930557
2,2'-(5,5',10,10'-tetrahydroxy-1,1'-dimethyl-6,6',9,9'-tetraoxo-3,3',4,4',6,6',9,9'-octahydro-1h,1'h-[8,8'-binaphtho[2,3-c]pyran]-3,3'-diyl)diacetic acid
2-[(1r,3s)-8-[(1r,3s)-3-(carboxymethyl)-5,6,9,10-tetrahydroxy-1-methyl-3,4-dihydro-1h-benzo[g]isochromen-8-yl]-1-methyl-5,6,9,10-tetraoxo-3,4-dihydro-1h-benzo[g]isochromen-3-yl]acetic acid

Research Excerpts

Overview

Actinorhodin is a blue-pigmented, redox-active secondary metabolite. It is produced by the bacterium Streptomyces coelicolor.

ExcerptReferenceRelevance
"Actinorhodin (ACT) is a benzoisochromanequinone antibiotic produced by Streptomyces coelicolor A3(2), which has served as a favored model organism for comprehensive studies of antibiotic biosynthesis and its regulation. "( Characterization of stereospecific enoyl reductase ActVI-ORF2 for pyran ring formation in the actinorhodin biosynthesis of Streptomyces coelicolor A3(2).
Hashimoto, M; Ichinose, K; Ishikawa, K; Komatsu, K; Okamoto, S; Taguchi, T, 2022
)
2.38
"Actinorhodin is a blue-pigmented, redox-active secondary metabolite that is produced by the bacterium Streptomyces coelicolor. "( Actinorhodin is a redox-active antibiotic with a complex mode of action against Gram-positive cells.
Mak, S; Nodwell, JR, 2017
)
3.34
"Actinorhodin is a blue-pigmented antibiotic produced by Streptomyces coelicolor."( A two-step mechanism for the activation of actinorhodin export and resistance in Streptomyces coelicolor.
Au-Yeung, C; Nodwell, JR; Tahlan, K; Willems, A; Xu, Y, 2012
)
1.36
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (306)

TimeframeStudies, This Drug (%)All Drugs %
pre-19909 (2.94)18.7374
1990's70 (22.88)18.2507
2000's100 (32.68)29.6817
2010's107 (34.97)24.3611
2020's20 (6.54)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 32.04

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index32.04 (24.57)
Research Supply Index5.75 (2.92)
Research Growth Index5.36 (4.65)
Search Engine Demand Index44.85 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (32.04)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews10 (3.21%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other302 (96.79%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]